The journal retracts the article titled “Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of a number of images presented in this publication [1].
Adhering to our standard procedure, the Editorial Office and Editorial Board conducted an investigation that confirmed the duplication of a number of panels contained within Figure 5, presenting different experimental conditions. Following discussions with the authors, the Editorial Board was unable to accept the authors’ explanation or verify the validity of the above-mentioned images through evaluation of the supporting raw materials provided. Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal IJMS.
The authors do not agree with this retraction.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Cordaro M., Siracusa R., D’Amico R., Genovese T., Franco G., Marino Y., Di Paola D., Cuzzocrea S., Impellizzeri D., Di Paola R., et al. RETRACTED: Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia. Int. J. Mol. Sci. 2022;23:6139. doi: 10.3390/ijms23116139. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]